Island Pharmaceuticals LtdASX: ILA

Phase 2a PROTECT clinical trial dosed & Investor webinar

Oct 3, 2024 at 3:32 AM UTC · Issued by Island Pharmaceuticals Ltd

Island Pharmaceuticals Ltd has released a press release.

View Attachment